Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Johnson

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Canadian Medical Association Journal|March 24, 2010
Safety LastW M Johnson
Hematology. American Society of Hematology. Education Program|December 4, 2016
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?Peter W M Johnson
British Journal of Cancer|October 1, 2008
Survival from non-Hodgkin lymphoma in England and Wales up to 2001P W M Johnson
Blood|June 23, 2022
Smart salvage treatment for Hodgkin lymphomaPeter W M Johnson
Hematology. American Society of Hematology. Education Program|December 10, 2013
Management of early-stage Hodgkin lymphoma: is there still a role for radiation?Peter W M Johnson
Hematological Oncology|June 9, 2023
Are we reaching the maximum cure rate for Hodgkin lymphoma?Peter W M Johnson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
New targets for lymphoma treatmentP W M Johnson
Hematological Oncology|June 11, 2015
IV. Masses in the mediastinum: primary mediastinal lymphoma and intermediate typesPeter W M Johnson
Experientia|May 15, 1991
Application of the polymerase chain reaction (PCR) to detection of the aerolysin gene in whole cell cultures of beta-hemolytic Aeromonas hydrophilaH Lior, W M Johnson
Microbial Pathogenesis|February 1, 1988
A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter sppW M Johnson, H Lior
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Canadian Medical Association Journal|March 24, 2010
Safety LastW M Johnson
Hematology. American Society of Hematology. Education Program|December 4, 2016
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?Peter W M Johnson
British Journal of Cancer|October 1, 2008
Survival from non-Hodgkin lymphoma in England and Wales up to 2001P W M Johnson
Blood|June 23, 2022
Smart salvage treatment for Hodgkin lymphomaPeter W M Johnson
Hematology. American Society of Hematology. Education Program|December 10, 2013
Management of early-stage Hodgkin lymphoma: is there still a role for radiation?Peter W M Johnson
Hematological Oncology|June 9, 2023
Are we reaching the maximum cure rate for Hodgkin lymphoma?Peter W M Johnson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
New targets for lymphoma treatmentP W M Johnson
Hematological Oncology|June 11, 2015
IV. Masses in the mediastinum: primary mediastinal lymphoma and intermediate typesPeter W M Johnson
Experientia|May 15, 1991
Application of the polymerase chain reaction (PCR) to detection of the aerolysin gene in whole cell cultures of beta-hemolytic Aeromonas hydrophilaH Lior, W M Johnson
Microbial Pathogenesis|February 1, 1988
A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter sppW M Johnson, H Lior
Pageof 22